TNF — Drug Target
All drugs that target TNF — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (2)
- TNFR:Fc · National Eye Institute (NEI) · TNF inhibitor · Immunology
TNFR:Fc is a fusion protein that binds to tumor necrosis factor (TNF) and prevents it from interacting with its receptors on cell surfaces. - administration of Cimzia® · University Hospital, Ghent · TNF inhibitor · Immunology
Cimzia is a fully human monoclonal antibody that selectively binds to tumor necrosis factor (TNF) and blocks its interaction with cell surface TNF receptors.
Phase 2 pipeline (1)
- Baminercept alfa 4 · Biogen · TNF inhibitor · Rheumatology
Baminercept alfa 4 is a fusion protein that targets and binds to the soluble form of tumor necrosis factor (TNF) to prevent its interaction with cell surface TNF receptors.